Research articles
-
Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms
Part of Cellular and molecular neurobiology, p. 3023-3035, 2023.
DOI for Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms Download full text (pdf) of Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms
-
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
Part of Fluids and Barriers of the CNS, 2023.
DOI for Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody Download full text (pdf) of Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
-
Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
Part of Alzheimer's Research & Therapy, 2023.
DOI for Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease Download full text (pdf) of Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
-
Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes
Part of Molecular and Cellular Neuroscience, 2023.
DOI for Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes Download full text (pdf) of Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes
-
Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function
Part of Journal of Neuroinflammation, 2023.
DOI for Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function Download full text (pdf) of Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function
-
The G51D SNCA mutation generates a slowly progressive alpha-synuclein strain in early-onset Parkinson's disease
Part of Acta neuropathologica communications, 2023.
DOI for The G51D SNCA mutation generates a slowly progressive alpha-synuclein strain in early-onset Parkinson's disease Download full text (pdf) of The G51D SNCA mutation generates a slowly progressive alpha-synuclein strain in early-onset Parkinson's disease
-
Size matters: the impact of nucleus size on results from spatial transcriptomics
Part of Journal of Translational Medicine, 2023.
DOI for Size matters: the impact of nucleus size on results from spatial transcriptomics Download full text (pdf) of Size matters: the impact of nucleus size on results from spatial transcriptomics
-
Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology
Part of Acta neuropathologica communications, 2023.
DOI for Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology Download full text (pdf) of Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology
-
Genetic insights into resting heart rate and its role in cardiovascular disease
Part of Nature Communications, 2023.
DOI for Genetic insights into resting heart rate and its role in cardiovascular disease Download full text (pdf) of Genetic insights into resting heart rate and its role in cardiovascular disease
-
Amyloid-beta accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism
Part of Journal of Neuroinflammation, 2023.
DOI for Amyloid-beta accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism Download full text (pdf) of Amyloid-beta accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism
-
Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice
Part of Brain and Behavior, 2022.
DOI for Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice Download full text (pdf) of Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Part of Nature Genetics, p. 412-436, 2022.
DOI for New insights into the genetic etiology of Alzheimer's disease and related dementias Download full text (pdf) of New insights into the genetic etiology of Alzheimer's disease and related dementias
-
Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
Part of Alzheimer's Research & Therapy, 2022.
DOI for Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping Download full text (pdf) of Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
-
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein
Part of Translational Neurodegeneration, 2022.
DOI for ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein Download full text (pdf) of ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein
-
A beta and tau prions feature in the neuropathogenesis of Down syndrome
Part of Proceedings of the National Academy of Sciences of the United States of America, 2022.
DOI for A beta and tau prions feature in the neuropathogenesis of Down syndrome
-
Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
Part of Scientific Reports, 2022.
DOI for Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3 Download full text (pdf) of Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
-
Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies
Part of Pharmaceutical research, p. 1509-1521, 2022.
DOI for Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies Download full text (pdf) of Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies
-
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Part of Acta Neuropathologica, p. 821-842, 2022.
DOI for Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers Download full text (pdf) of Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
-
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis
Part of Acta neuropathologica communications, 2022.
DOI for Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis Download full text (pdf) of Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis
-
Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
Part of Fluids and Barriers of the CNS, 2022.
DOI for Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis Download full text (pdf) of Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
-
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
Part of Molecular Therapy Nucleic Acids, p. 450-461, 2022.
DOI for CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation Download full text (pdf) of CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
-
Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
Part of Journal of Alzheimer's Disease, p. 1601-1614, 2022.
DOI for Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation Download full text (pdf) of Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
-
11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
Part of Journal of Nuclear Medicine, p. 302-309, 2022.
DOI for 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention Download full text (pdf) of 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
-
Passive and receptor mediated brain delivery of an anti-GFAP nanobody
Part of Nuclear Medicine and Biology, p. 128-134, 2022.
DOI for Passive and receptor mediated brain delivery of an anti-GFAP nanobody Download full text (pdf) of Passive and receptor mediated brain delivery of an anti-GFAP nanobody
-
Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
Part of BMC Genomics, 2022.
DOI for Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia Download full text (pdf) of Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
-
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
Part of NEUROTHERAPEUTICS, p. 1588-1602, 2022.
DOI for A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice Download full text (pdf) of A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
-
Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
Part of Alzheimer's Research & Therapy, 2022.
DOI for Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease Download full text (pdf) of Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
-
Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
Part of Pharmaceutics, 2022.
DOI for Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody Download full text (pdf) of Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
-
Targeted Gene Therapy to Treat Disorders of the Central Nervous System
Part of Movement Disorders, p. 892-892, 2022.
DOI for Targeted Gene Therapy to Treat Disorders of the Central Nervous System
-
Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
Part of Molecular Pharmaceutics, p. 4111-4122, 2022.
DOI for Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging Download full text (pdf) of Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
-
Professor Margareta Hammarlund-Udenaes: a Modern and Visionary Mentor
Part of Pharmaceutical research, p. 1291-1296, 2022.
DOI for Professor Margareta Hammarlund-Udenaes: a Modern and Visionary Mentor
-
PET Imaging in Preclinical Anti-Aβ Drug Development
Part of Pharmaceutical research, p. 1481-1496, 2022.
DOI for PET Imaging in Preclinical Anti-Aβ Drug Development Download full text (pdf) of PET Imaging in Preclinical Anti-Aβ Drug Development
-
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease
Part of Alzheimer’s & Dementia, 2022.
DOI for VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease Download full text (pdf) of VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease
-
Differential DNA methylation of the genes for amyloid precursor protein, tau and neurofilaments in human traumatic brain injury
Part of Journal of Neurotrauma, p. 1679-1688, 2021.
-
Visualization of early oligomeric α‐synuclein pathology and its impact on the dopaminergic system in the (Thy‐1)‐h[A30P]α‐syn transgenic mouse model
Part of Journal of Neuroscience Research, p. 2525-2539, 2021.
DOI for Visualization of early oligomeric α‐synuclein pathology and its impact on the dopaminergic system in the (Thy‐1)‐h[A30P]α‐syn transgenic mouse model Download full text (pdf) of Visualization of early oligomeric α‐synuclein pathology and its impact on the dopaminergic system in the (Thy‐1)‐h[A30P]α‐syn transgenic mouse model
-
Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
Part of Annals of Clinical and Translational Neurology, p. 1456-1470, 2021.
DOI for Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease Download full text (pdf) of Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
-
Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid
Part of Journal of Alzheimer's Disease, p. 629-640, 2021.
DOI for Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid Download full text (pdf) of Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid
-
The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation
Part of Science Translational Medicine, 2021.
-
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Part of Nature Communications, 2021.
DOI for Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores Download full text (pdf) of Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
-
Immune cells lacking Y chromosome show dysregulation of autosomal gene expression
Part of Cellular and Molecular Life Sciences (CMLS), p. 4019-4033, 2021.
DOI for Immune cells lacking Y chromosome show dysregulation of autosomal gene expression Download full text (pdf) of Immune cells lacking Y chromosome show dysregulation of autosomal gene expression
-
Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
Part of Fluids and Barriers of the CNS, 2021.
DOI for Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size Download full text (pdf) of Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size